Though much of the dust has settled around Novo Nordisk and Eli Lilly’s crusade against compounded GLP-1s, the recent ...

More and more people are taking weight loss injections, but not everyone is aware of how they actually work or their side ...

A handful of New York City restaurants have been putting smaller portion sizes on their menus amid the rise of weight-loss ...

T he effectiveness of modern drugs like Ozempic and Mounjaro has helped revolutionize weight loss and the health issues that ...

MHRA launches genetic study into GLP-1 drug risks as Spain investigates Novo Nordisk for potential advertising violations.

Adults with type 2 diabetes and chronic kidney disease have a lower risk for adverse renal outcomes with semaglutide, ...

People with type 1 diabetes who need to lose weight can benefit from the blockbuster GLP-1 drug semaglutide currently ...

In the UK, investors will be looking at the latest shop price index from the British Retail Consortium (BRC), particularly ...

At least 10 people have now died following side-effects allegedly caused by GLP-1 weight loss jabs. Over a million people ...

Access is opening up for Kiwis to a weight loss drug described as a game changer. Wegovy, made by pharma-co Novo Nordisk, ...

Spain is investigating Novo Nordisk over concerns it may be indirectly marketing its weight loss drugs. Euronews Health spoke ...